Menu
Recruiting NCT07280338

Emotional Intelligence and Chronic Orofacial Pain

Observational Chronic Pain

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Questionnaire and Physical Exam.
Who it may be relevant to
Registry conditions: Chronic Pain. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Chronic pain, lasting more than three months, is a widespread health issue that negatively impacts daily life, leading to significant emotional distress and functional impairment. Emotional intelligence, defined as the ability to recognize and manage one's own emotions as well as those of others, has been linked to better communication skills and reduced stress, which is a well-known risk factor for chronic pain. Studies have highlighted a correlation between emotional intelligence and certain chronic pain conditions, such as fibromyalgia and migraines. However, no research has yet explored its role in painful temporomandibular disorders (TMD). Given the strong involvement of psychosocial factors in TMD etiology, a better understanding of these elements could improve pain management and pave the way for preventive interventions.

Detailed description

This project aims to compare emotional intelligence and various psychosocial factors (anxiety, depression, coping, emotional regulation) between patients with painful temporomandibular disorder (TMD) and a control group without TMD or chronic pain. The study is based on the administration of validated French-language questionnaires during routine dental medicine consultations. Each participant completes these questionnaires in approximately 15 minutes, without any modification to their care. The data collected will help assess the relationships between orofacial pain and emotional factors to improve the understanding and management of affected patients.

Interventions

  • Other Questionnaire and Physical Exam
    All included subjects will be required to complete the following questionnaires: Hospital Anxiety and Depression Scale (HADS) Brief-COPE for coping assessment Emotion Reactivity Scale (ERS) for emotional regulation Visual Analog Scale (VAS) for fatigue assessment Sociodemographic and psychosocial evaluation Trait Emotional Intelligence Questionnaire - Short Form (TEIQue-SF) for emotional intelligence assessment

Primary outcome measures

  • Measurement of emotional intelligence score between both groups [Time frame: Day 0]
Secondary outcome measures (5)
  • Measurement of anxiety disorders between both groups [Time frame: Day 0]
  • Measurement of the coping score between both groups [Time frame: Day 0]
  • Measurement of emotional regulation score between both groups [Time frame: Day 0]
  • Measurement of fatigue score between both groups [Time frame: Day 0]
  • Measurement of Depression disorders between both groups [Time frame: Day 0]

Eligibility criteria

Inclusion criteria

For all subjects:

Major subject

  • Non-opposition obtained
  • For subjects in the TMD group:

Diagnosis of temporomandibular dysfunction -No other diagnosis of chronic pain

For subjects in the control group:

-No diagnosis of chronic pain

Non inclusion Criteria:

  • Subject not understanding French
  • Subject under legal protection (guardianship or curatorship)
  • Refusal to participate

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Case-only

Study locations

France · 1 center
  • CHU DE BREST - Médecine bucco-dentaire — Brest

Identifiers

NCT: NCT07280338 · 29BRC24.0372 · 2025-A00682-47

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗